The so-called Golden Triangle partnership, which brings together the Eastern Region Biotech Initiative based in Cambridge the Oxford Bioscience Network and the London Biotechnology Network, says the agreement with MassBio will encourage collaborations between each group’s member companies. The partners will promote each other’s investment and networking events to their respective members.
“This signifies an important step we are taking to extend our network globally with the intention to increase deal flow with Massachusetts companies and investors by facilitating introductions and presenting opportunities,” said ERBI Chief Executive Harriet Fear.
“This is a significant partnership that brings together the trade groups for two of the world’s largest life sciences clusters,” said Robert Coughlin, President & CEO of MassBio.
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening. 
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.
